ポイントオブケア検査市場：製品別、エンドユーザー別-2025～2030年の世界予測

ポイントオブケア検査市場は、2023年に289億米ドルと評価され、2024年には325億6,000万米ドルに達すると予測され、CAGR 12.75%で成長し、2030年には669億8,000万米ドルに達すると予測されています。

ポイントオブケア検査（POCT）は、患者の診療現場またはその近くでの医療診断検査を包含し、迅速な臨床管理決定を可能にする結果を即座に記載しています。POCTの必要性は、疾病管理の効率化、入院期間の短縮、集中検査室への負担軽減の可能性にあり、慢性疾患の蔓延が進む中、迅速な診断に対する需要の高まりに応えるものです。POCTの用途は、糖尿病管理、感染症検査、心血管診断から、重症患者ケアや妊娠検査まで幅広く、病院、クリニック、在宅医療の現場で不可欠です。市場の成長は、小型化、優れた精度、医療ITシステムとの統合などの技術的進歩に加え、自己検査を提唱する医療消費者の傾向の高まりが後押ししています。しかし、厳しい規制の枠組み、従来のラボ検査に比べて高い検査単価、オペレーターのミスや不十分なトレーニングによる結果のばらつきといった課題に直面しており、これが市場の成長を阻害する可能性があります。

市場における革新的な道筋としては、診断精度とリアルタイムモニタリング機能を強化するための人工知能と機械学習の統合、複数の検査を同時に処理するための多機能機器の開拓、遠隔医療機能を拡大するワイヤレスまたはスマートフォン対応機器などが挙げられます。企業はまた、集中型医療施設へのアクセスが限られている新興市場において、慢性疾患管理のためのPOCTの拡大に資本投下すべきです。最適な市場ポジショニングのために、利害関係者は研究開発の進歩のためにパートナーシップを結び、サービス提供の改善を促進するために医療プロバイダーとの戦略的提携を模索すべきです。市場競争が激しく、技術進歩の影響を受けやすいという市場の性質を認識した上で、利害関係者は費用対効果の高いソリューション、検査精度の向上、使いやすいインターフェースの開拓に注力することが推奨されます。規制上の課題やコスト面での障壁はあるもの、臨床現場や在宅環境における迅速診断検査に対する需要の高まりは、機器の差別化や業務効率化における継続的な技術革新の必要性に裏打ちされた、力強い成長機会を示しています。

市場力学：急速に進化するポイントオブケア検査市場の主要市場洞察を公開

ポイントオブケア検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の慢性・感染症罹患率の増加
  • POC検査の採用対する政府の好意的なポリシー
  • 新しい先進的検査キットによる患者中心のケア強化への潜在的需要
• 市場抑制要因
  • 製品開発コストが比較的高い
• 市場機会
  • メーカーによる研究開発投資の急増
  • POC検査の技術的進歩
• 市場課題
  • POC検査キットの承認に時間がかかる規制ポリシー

ポーターのファイブフォース：ポイントオブケア検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ポイントオブケア検査市場における外部からの影響の把握

外部マクロ環境要因は、ポイントオブケア検査市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：ポイントオブケア検査市場における競合情勢の把握

ポイントオブケア検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：ポイントオブケア検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ポイントオブケア検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：ポイントオブケア検査市場における成功への道筋を描く

ポイントオブケア検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患と感染症の発生が世界中で増加
    • POC検査イントロダクション対する政府の好意的なポリシー
    • 新しい先進的検査キットによる患者中心のケアの強化に対する潜在的な需要
  • 抑制要因
    • 製品開発にかかるコストが比較的高い
  • 機会
    • メーカーによる研究開発投資の急増
    • POCテストにおける技術的進歩
  • 課題
    • POC検査キットの承認には時間がかかる規制ポリシー
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 ポイントオブケア検査市場：製品別

• イントロダクション
• 心臓代謝モニタリングキット
• コレステロール検査ストリップ
• 不妊・妊娠検査キット
• 血糖値モニタリングキット
• 血液検査キット
• 感染症検査キット

第7章 ポイントオブケア検査市場：エンドユーザー別

• イントロダクション
• 外来診療
• 在宅医療
• 病院または集中治療室
• 外来医療
• 研究所

第8章 南北アメリカのポイントオブケア検査市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋のポイントオブケア検査市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのポイントオブケア検査市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• ACON Laboratories, Inc.
• Alere Inc
• Ativa Medical Corporation
• Becton, Dickinson, and Company
• BIOMERIEUX SA
• Chembio Diagnostics
• Danaher Corporation
• EKF Diagnostics Holdings plc
• Henry Schein, Inc
• Informa PLC
• Instrumentation Laboratory Company
• Johnson and Johnson Service, Inc.
• Medtronic plc
• Polymer Technology Systems, Inc.
• QIAGEN GmbH
• Roche Holding AG
• Siemens AG
• Sienco, Inc.
• WerfenLife, S.A.

LIST OF FIGURES

• FIGURE 1. POINT OF CARE TESTING MARKET RESEARCH PROCESS
• FIGURE 2. POINT OF CARE TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. POINT OF CARE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. POINT OF CARE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. POINT OF CARE TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. POINT OF CARE TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIO-METABOLIC MONITORING KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHOLESTEROL TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FERTILITY & PREGNANCY TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE MONITORING KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HAEMATOLOGY TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS OR CRITICAL CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OUTPATIENT HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. CANADA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. CANADA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. AUSTRALIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. AUSTRALIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. CHINA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. CHINA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. INDIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. INDIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. INDONESIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. INDONESIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. JAPAN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. JAPAN POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. MALAYSIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. MALAYSIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. PHILIPPINES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. PHILIPPINES POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. SINGAPORE POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. SINGAPORE POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. SOUTH KOREA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. SOUTH KOREA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. TAIWAN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. TAIWAN POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. THAILAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. THAILAND POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. VIETNAM POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. VIETNAM POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. DENMARK POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. DENMARK POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. EGYPT POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. EGYPT POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. FINLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. FINLAND POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. FRANCE POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. FRANCE POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. GERMANY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. GERMANY POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. ITALY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. ITALY POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. NORWAY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. NORWAY POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. POLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. POLAND POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. QATAR POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. QATAR POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. SPAIN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. SPAIN POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. SWITZERLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. SWITZERLAND POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. TURKEY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. TURKEY POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. POINT OF CARE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 107. POINT OF CARE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Point of Care Testing Market was valued at USD 28.90 billion in 2023, expected to reach USD 32.56 billion in 2024, and is projected to grow at a CAGR of 12.75%, to USD 66.98 billion by 2030.

Point of Care Testing (POCT) encompasses medical diagnostic testing at or near the site of patient care, offering immediate results that enable rapid clinical management decisions. The necessity for POCT lies in its potential to enhance disease management efficiencies, reduce hospital stays, and alleviate the pressure on centralized laboratories, thus catering to the increasing demand for rapid diagnostics amidst a growing prevalence of chronic diseases. POCT applications range from diabetes management, infectious disease testing, and cardiovascular diagnostics to critical care and pregnancy testing, vital across hospitals, clinics, and home care settings. Market growth is propelled by technological advancements such as miniaturization, superior accuracy, integration with health IT systems, along with a rising healthcare consumerism trend advocating for self-testing. However, the market faces challenges like stringent regulatory frameworks, higher costs per test compared with traditional lab tests, and variability in results due to operator error or inadequate training, which can impede growth.

Innovative pathways in the market include the integration of artificial intelligence and machine learning to enhance diagnostic accuracy and real-time monitoring capabilities, development of multifunctional devices to process multiple tests concurrently, and wireless or smartphone-compatible devices expanding telehealth capabilities. Companies should also capitalize on expanding POCT for chronic conditions management in emerging markets where access to centralized healthcare facilities is limited. For optimal market positioning, stakeholders should engage in partnerships for R&D advancements and seek strategic alliances with healthcare providers to facilitate service delivery improvements. Recognizing the market's nature as highly competitive and influenced by technological progressions, stakeholders are recommended to focus on cost-effective solutions, increased test precision, and user-friendly interface development. Despite regulatory challenges and cost barriers, the increasing demand for rapid diagnostic tests in clinical and home settings presents a robust growth opportunity, underlined by a necessity for continuous innovation in device differentiation and operational efficiency.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Point of Care Testing Market

The Point of Care Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of chronic and infectious diseases globally
  • Favorable government policies for introduction of POC testing
  • Potential demand for enhanced patient-centric care with new advanced testing kits
• Market Restraints
  • Relatively high cost involved in product development
• Market Opportunities
  • Surge in research and development investment by manufacturers
  • Technological advancements in POC testing
• Market Challenges
  • Time-consuming regulatory policies for approval of POC testing kits

Porter's Five Forces: A Strategic Tool for Navigating the Point of Care Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Point of Care Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Point of Care Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Point of Care Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Point of Care Testing Market

A detailed market share analysis in the Point of Care Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Point of Care Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Point of Care Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Point of Care Testing Market

A strategic analysis of the Point of Care Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Point of Care Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Alere Inc, Ativa Medical Corporation, Becton, Dickinson, and Company, BIOMERIEUX SA, Chembio Diagnostics, Danaher Corporation, EKF Diagnostics Holdings plc, Henry Schein, Inc, Informa PLC, Instrumentation Laboratory Company, Johnson and Johnson Service, Inc., Medtronic plc, Polymer Technology Systems, Inc., QIAGEN GmbH, Roche Holding AG, Siemens AG, Sienco, Inc., and WerfenLife, S.A..

Market Segmentation & Coverage

This research report categorizes the Point of Care Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cardio-Metabolic Monitoring Kits, Cholesterol Test Strips, Fertility & Pregnancy Testing Kits, Glucose Monitoring Kits, Haematology Testing Kits, and Infectious Disease Testing Kits.
• Based on End-User, market is studied across Ambulatory Care, Home Care, Hospitals or Critical Care, Outpatient Healthcare, and Research Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of chronic and infectious diseases globally
    • 5.1.1.2. Favorable government policies for introduction of POC testing
    • 5.1.1.3. Potential demand for enhanced patient-centric care with new advanced testing kits
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively high cost involved in product development
  • 5.1.3. Opportunities
    • 5.1.3.1. Surge in research and development investment by manufacturers
    • 5.1.3.2. Technological advancements in POC testing
  • 5.1.4. Challenges
    • 5.1.4.1. Time-consuming regulatory policies for approval of POC testing kits
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Point of Care Testing Market, by Product

• 6.1. Introduction
• 6.2. Cardio-Metabolic Monitoring Kits
• 6.3. Cholesterol Test Strips
• 6.4. Fertility & Pregnancy Testing Kits
• 6.5. Glucose Monitoring Kits
• 6.6. Haematology Testing Kits
• 6.7. Infectious Disease Testing Kits

7. Point of Care Testing Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Care
• 7.3. Home Care
• 7.4. Hospitals or Critical Care
• 7.5. Outpatient Healthcare
• 7.6. Research Laboratories

8. Americas Point of Care Testing Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Point of Care Testing Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Point of Care Testing Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. ACON Laboratories, Inc.
• 3. Alere Inc
• 4. Ativa Medical Corporation
• 5. Becton, Dickinson, and Company
• 6. BIOMERIEUX SA
• 7. Chembio Diagnostics
• 8. Danaher Corporation
• 9. EKF Diagnostics Holdings plc
• 10. Henry Schein, Inc
• 11. Informa PLC
• 12. Instrumentation Laboratory Company
• 13. Johnson and Johnson Service, Inc.
• 14. Medtronic plc
• 15. Polymer Technology Systems, Inc.
• 16. QIAGEN GmbH
• 17. Roche Holding AG
• 18. Siemens AG
• 19. Sienco, Inc.
• 20. WerfenLife, S.A.